Dr. Martens Boots Recalled Over Chemical Hazard

More than 30,000 Dr. Martens Vegan boots have been recalled due to a risk of problems that may be caused by prolonged exposure to a chemical on the tongue lining, which may cause allergic reactions or other injuries. 

The Dr. Martens boots recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on August 24, indicating that consumers may experience problems following prolonged and direct contact with the chemical benzidine inside the boot lining.

Exposure to the chemical benzidine may cause skin allergies or rashes that may swell, blister and become irritated, cause discomfort.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall includes about 30,900 Dr. Martens unisex Vegan 1460 eight eye boots, which are marked with the product code 14585 printed on the tongue label. The boots are black cherry in color and have black shoe laces with a thick sole and a golden heel pull tab marked with the manufacturer name, “AirWair”. All sizes are included in the recall and the shoes are marked with batch code starting with “GV” and end with either Q, R, or S.

According to the CPSC, an estimated 30,000 pairs of the recalled boots were distributed for sale throughout the United States, and an additional 900 were distributed for sale in Canada.

The recalled Dr. Martens boots were manufactured in Vietnam under Airwair of Portland, Oregon. They were sold at Dr. Martens, Journeys and independent retail stores nationwide as well as online at Amazon.com, Dr.Martens.com, Shoebuy.com, and other online retailers from January 2015 through July 2017 for about $125.

The CPSC is encouraging all customers to stop wearing the boots immediately and to contact Dr. Martens for a full refund or free replacement product by contacting the manufacturers customer service department at 800-460-3930 or emailing them at dmservice@drmartens.com. Customers may also visit the company’s website at www.drmartens.com and navigate to the “Product Recall” link for additional information.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted today)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted yesterday)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted yesterday)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.